| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0febe26c2f3dd5cd78bbd1e22f03c4e9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138 |
| filingDate |
1997-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32216c3f5aa688f04aff57220a52d30b |
| publicationDate |
1998-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9824381-A1 |
| titleOfInvention |
Method of improving outcome of cardiopulmonary bypass surgery |
| abstract |
A method of improving the clinical outcome of subjects undergoing cardiopulmonary bypass surgery, by peri-operatively or intra-operatively administering a therapeutically effective amount of an intravenous beta adrenergic antagonist, to inhibit tissue damage from ischemia. In a disclosed embodiment, the beta adrenergic antagonist is propranolol in a dose of at least 0.1 mg/kg. |
| priorityDate |
1996-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |